Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
PaperCitations, authors & open-access status
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 696 citations, 2014 year and closed oa status.
696
Citations
2014
Year
closed
OA Status